BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12598416)

  • 1. Activation of c-fos expression in the heart after morphine but not U-50,488H withdrawal.
    González-Cuello A; Milanés MV; Castells MT; Laorden ML
    Br J Pharmacol; 2003 Feb; 138(4):626-33. PubMed ID: 12598416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of U-50488H and U-50488H withdrawal on c-fos expression in the rat paraventricular nucleus. Correlation with c-fos in brainstem catecholaminergic neurons.
    Laorden ML; Castells MT; Milanés MV
    Br J Pharmacol; 2003 Apr; 138(8):1544-52. PubMed ID: 12721110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.
    Laorden ML; Castells MT; Martínez MD; Martínez PJ; Milanés MV
    Endocrinology; 2000 Apr; 141(4):1366-76. PubMed ID: 10746640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of U-50,488H withdrawal on catecholaminergic neurones of the rat ventricle.
    Milanés MV; Laorden ML
    Br J Pharmacol; 1998 Jul; 124(6):1060-4. PubMed ID: 9720773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine withdrawal-induced c-fos expression in the heart: a peripheral mechanism.
    González-Cuello A; Milanés MV; Castells MT; Laorden ML
    Eur J Pharmacol; 2004 Mar; 487(1-3):117-24. PubMed ID: 15033383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of U-50,488H and U-50,488H withdrawal on catecholaminergic neurons of the rat hypothalamus.
    Laorden ML; Milanés MV
    Life Sci; 2000 Jan; 66(9):803-15. PubMed ID: 10698355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of U-50,488H on isolated atria from rats chronically treated with the kappa-opioid agonist, U-50,488H.
    Milanés MV; Rabadan JV; Marin MT; Laorden ML
    J Auton Pharmacol; 1998 Dec; 18(6):371-5. PubMed ID: 9915602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of 3',5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos expression and tyrosine hydroxylase levels during morphine withdrawal in the hypothalamic paraventricular nucleus and medulla oblongata catecholaminergic cell groups.
    Benavides M; Laorden ML; Milanés MV
    J Neurochem; 2005 Jan; 92(2):246-54. PubMed ID: 15663473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of naloxone-precipitated morphine withdrawal on c-fos expression in rat corticotropin-releasing hormone neurons in the paraventricular hypothalamus and extended amygdala.
    Hamlin AS; Buller KM; Day TA; Osborne PB
    Neurosci Lett; 2004 May; 362(1):39-43. PubMed ID: 15147776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in c-fos expression in the rat heart during morphine withdrawal. Involvement of alpha2-adrenoceptors.
    González-Cuello A; Milanés MV; Aviles M; Laorden ML
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):17-25. PubMed ID: 15249992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential involvement of 3', 5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal.
    Almela P; Cerezo M; González-Cuello A; Milanés MV; Laorden ML
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Jan; 374(4):293-303. PubMed ID: 17216288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of PKC-alpha,gamma isoforms in regulation of c-Fos and TH expression after naloxone-induced morphine withdrawal in the hypothalamic PVN and medulla oblongata catecholaminergic cell groups.
    Benavides M; Laorden ML; Marín MT; Milanés MV
    J Neurochem; 2005 Dec; 95(5):1249-58. PubMed ID: 16190878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contralateral but not systemic administration of the kappa-opioid agonist U-50,488H induces anti-nociception in acute hindpaw inflammation in rats.
    Bileviciute-Ljungar I; Spetea M
    Br J Pharmacol; 2001 Jan; 132(1):252-8. PubMed ID: 11156584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the ERK signalling pathway contributes to the adaptive changes in rat hearts during naloxone-induced morphine withdrawal.
    Almela P; Milanés MV; Laorden ML
    Br J Pharmacol; 2007 Jul; 151(6):787-97. PubMed ID: 17549049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase 4 inhibitors, rolipram and diazepam block the adaptive changes observed during morphine withdrawal in the heart.
    González-Cuello A; Sánchez L; Hernández J; Teresa Castells M; Victoria Milanés M; Laorden ML
    Eur J Pharmacol; 2007 Sep; 570(1-3):1-9. PubMed ID: 17601555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus.
    Núñez C; González-Cuello A; Sánchez L; Vargas ML; Milanés MV; Laorden ML
    Eur J Pharmacol; 2009 Oct; 620(1-3):1-8. PubMed ID: 19683523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine or U-50,488 suppresses Fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitarii evoked by a noxious visceral stimulus in the rat.
    Hammond DL; Presley R; Gogas KR; Basbaum AI
    J Comp Neurol; 1992 Jan; 315(2):244-53. PubMed ID: 1545011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of morphine and U-50,488H on neurochemical activity of the hypothalamic noradrenergic neurons and pituitary-adrenal response.
    Laorden ML; Milanés MV
    Neuropeptides; 1999 Apr; 33(2):131-5. PubMed ID: 10657482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of PKC in regulation of Fos and TH expression after naloxone induced morphine withdrawal in the heart.
    Almela P; Cerezo M; Milanés MV; Laorden ML
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb; 372(5):374-82. PubMed ID: 16474935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of tyrosine hydroxylase levels and activity during morphine withdrawal in the heart.
    González-Cuello A; Milanés MV; Laorden ML
    Eur J Pharmacol; 2004 Dec; 506(2):119-28. PubMed ID: 15588731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.